Company profile
Omnicell, Inc.
NASDAQ: OMCL · Healthcare · Medical - Equipment & Services
#142 of 1,418 Healthcare companies by revenue51st-percentile growth
EA Score
78B+FH 79DQ 85GM 56SS 86
v0.1 · 65/100 weight · provisional
↑ Piotroski F, workforce scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$1.2B
Rev growth YoY (TTM)
+7.9%
Net income (FY)
$2.1M
Employees
3,580
as of 2026-08-09
Market cap
$1.7B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.2B$1.2B2025
Net income$2.1M$2.1M2025
Operating income$5.2M$5.2M2025
Total assets$2.0B$2.0B2025
Liabilities$742.9M$742.9M2025
Equity$1.2B$1.2B2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Connected Devices, Software Licenses, And Other48%
Technical Services22%
Hardware And Software22%
Consumables8%
By geography
UNITED STATES90%
Non-US10%
The read
What is Omnicell, Inc.’s revenue?
Omnicell, Inc. booked $1.2B in FY2025 revenue, growing 6.5% year over year — about the middle of the pack among Healthcare companies we track, at a 0.2% net margin.
Peers · Healthcare
Indivior Pharmaceuticals Inc67BBio-Techne Corporation85AExtendicare Inc.79B+Trulieve Cannabis Corp.63CTrulieve Cannabis Corp.——Green Thumb Industries Inc.72BNeighbors
Tarrant →Key facts
CEORandall A. Lipps
SectorHealthcare
IndustryMedical - Equipment & Services
HeadquartersFort Worth, TX
ExchangeNASDAQ: OMCL
Employees3,580
IPO date2001-08-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.